Summary Randomized trials provide the strongest evidence to guide clinical care, and they usually collect detailed data on a large number of patients. These individual patient data (IPD) should be used to their fullest potential, also including purposes other than those they were collected for. To succeed, IPD must be shared with other researchers. Here we present the history of IPD sharing, the past and current proportions of hepatology trials stating their willingness to share IPD, and our own experience with reuse of IPD data from hepatology trials.
Jepsen et al. (Fri,) studied this question.